More than an accessory: Implications of type III transforming growth factor-β receptor loss in prostate cancer

Seun Ajiboye; Tristan M. Sissung; Nima Sharifi; William D. Figg

doi:10.1111/j.1464-410X.2009.08999.x

More than an accessory: Implications of type III transforming growth factor-β receptor loss in prostate cancer

Seun Ajiboye, Tristan M. Sissung, Nima Sharifi, William D. Figg

Internal Medicine

Research output: Contribution to journal › Short survey › peer-review

16 Scopus citations

Abstract

The type III transforming growth factor-β receptor (TGFβR3, betaglycan), a tumour suppressor, is the most frequently lost TGFβ pathway component. This event appears to be very important in the transition of the TGFβ pathway from having tumour-suppressor activity in early prostate tumour development, to having tumour-promoting activity in metastatic disease. Moreover, loss of the TGFβR3 can also affect the cellular response towards testosterone, inhibin/activin, and dysregulate growth-factor pathways that mediate growth and angiogenesis. In this review we discuss how TGFβR3 normally functions as an accessory protein in the TGFβ pathway, how its loss is related to tumour progression, and the treatment implications of TGFβR3 loss in individuals with prostate cancer.

Original language	English (US)
Pages (from-to)	913-916
Number of pages	4
Journal	BJU international
Volume	105
Issue number	7
DOIs	https://doi.org/10.1111/j.1464-410X.2009.08999.x
State	Published - Apr 2010

Keywords

Betaglycan
Prostate cancer
TGFβ III receptor
Testosterone

ASJC Scopus subject areas

Urology

Access to Document

10.1111/j.1464-410X.2009.08999.x

Cite this

@article{0ceec998351a45cd8d2b643d89a77707,

title = "More than an accessory: Implications of type III transforming growth factor-β receptor loss in prostate cancer",

abstract = "The type III transforming growth factor-β receptor (TGFβR3, betaglycan), a tumour suppressor, is the most frequently lost TGFβ pathway component. This event appears to be very important in the transition of the TGFβ pathway from having tumour-suppressor activity in early prostate tumour development, to having tumour-promoting activity in metastatic disease. Moreover, loss of the TGFβR3 can also affect the cellular response towards testosterone, inhibin/activin, and dysregulate growth-factor pathways that mediate growth and angiogenesis. In this review we discuss how TGFβR3 normally functions as an accessory protein in the TGFβ pathway, how its loss is related to tumour progression, and the treatment implications of TGFβR3 loss in individuals with prostate cancer.",

keywords = "Betaglycan, Prostate cancer, TGFβ III receptor, Testosterone",

author = "Seun Ajiboye and Sissung, {Tristan M.} and Nima Sharifi and Figg, {William D.}",

year = "2010",

month = apr,

doi = "10.1111/j.1464-410X.2009.08999.x",

language = "English (US)",

volume = "105",

pages = "913--916",

journal = "BJU international",

issn = "1464-4096",

publisher = "Wiley-Blackwell",

number = "7",

}

TY - JOUR

T1 - More than an accessory

T2 - Implications of type III transforming growth factor-β receptor loss in prostate cancer

AU - Ajiboye, Seun

AU - Sissung, Tristan M.

AU - Sharifi, Nima

AU - Figg, William D.

PY - 2010/4

Y1 - 2010/4

N2 - The type III transforming growth factor-β receptor (TGFβR3, betaglycan), a tumour suppressor, is the most frequently lost TGFβ pathway component. This event appears to be very important in the transition of the TGFβ pathway from having tumour-suppressor activity in early prostate tumour development, to having tumour-promoting activity in metastatic disease. Moreover, loss of the TGFβR3 can also affect the cellular response towards testosterone, inhibin/activin, and dysregulate growth-factor pathways that mediate growth and angiogenesis. In this review we discuss how TGFβR3 normally functions as an accessory protein in the TGFβ pathway, how its loss is related to tumour progression, and the treatment implications of TGFβR3 loss in individuals with prostate cancer.

AB - The type III transforming growth factor-β receptor (TGFβR3, betaglycan), a tumour suppressor, is the most frequently lost TGFβ pathway component. This event appears to be very important in the transition of the TGFβ pathway from having tumour-suppressor activity in early prostate tumour development, to having tumour-promoting activity in metastatic disease. Moreover, loss of the TGFβR3 can also affect the cellular response towards testosterone, inhibin/activin, and dysregulate growth-factor pathways that mediate growth and angiogenesis. In this review we discuss how TGFβR3 normally functions as an accessory protein in the TGFβ pathway, how its loss is related to tumour progression, and the treatment implications of TGFβR3 loss in individuals with prostate cancer.

KW - Betaglycan

KW - Prostate cancer

KW - TGFβ III receptor

KW - Testosterone

UR - http://www.scopus.com/inward/record.url?scp=77749290000&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77749290000&partnerID=8YFLogxK

U2 - 10.1111/j.1464-410X.2009.08999.x

DO - 10.1111/j.1464-410X.2009.08999.x

M3 - Short survey

C2 - 20067462

AN - SCOPUS:77749290000

SN - 1464-4096

VL - 105

SP - 913

EP - 916

JO - BJU international

JF - BJU international

IS - 7

ER -

More than an accessory: Implications of type III transforming growth factor-β receptor loss in prostate cancer

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this